关注
Bret Miller
Bret Miller
未知所在单位机构
在 brown.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells
IC Kurt, R Zhou, S Iyer, SP Garcia, BR Miller, LM Langner, J Grünewald, ...
Nature biotechnology 39 (1), 41-46, 2021
5192021
A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing
J Grünewald, R Zhou, CA Lareau, SP Garcia, S Iyer, BR Miller, ...
Nature biotechnology 38 (7), 861-864, 2020
2422020
Engineered CRISPR prime editors with compact, untethered reverse transcriptases
J Grünewald, BR Miller, RN Szalay, PK Cabeceiras, CJ Woodilla, ...
Nature Biotechnology 41 (3), 337-343, 2023
692023
Near-infrared fluorescent northern blot
BR Miller, T Wei, CJ Fields, P Sheng, M Xie
Rna 24 (12), 1871-1877, 2018
482018
Northern blot with IR fluorescent probes: strategies for probe preparation
C Fields, P Sheng, B Miller, T Wei, M Xie
Bio-protocol 9 (8), e3219-e3219, 2019
162019
Base editing in hematopoietic cells corrects the disease underlying intronic mutation in a mouse model of familial hemophagocytic lymphohistiocytosis
L Lei, K Weissert, V Dettmer-Monaco, J Grunewald, MM Kaufmann, ...
HUMAN GENE THERAPY 33 (23-24), A22-A23, 2022
2022
Efficient Multiplex Base Editing at Single Target Sites with a Dual-Deaminase Base Editor
J Grunewald, R Zhou, CA Lareau, SP Garcia, S Iyer, JY Hsu, BR Miller, ...
MOLECULAR THERAPY 28 (4), 38-38, 2020
2020
Programmable C-to-G Transversions in Human Cells with Engineered CRISPR Base Editors
IC Kurt, R Zhou, S Iyer, SP Garcia, BR Miller, LM Langner, J Grunewald, ...
MOLECULAR THERAPY 28 (4), 37-37, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–8